ATGGF (Actinogen Medical) YoY Rev. per Sh. Growth : 0.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Actinogen Medical YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Actinogen Medical's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was 0.00%.

Actinogen Medical's Revenue per Share for the six months ended in Dec. 2023 was $0.00.

Actinogen Medical YoY Rev. per Sh. Growth Historical Data

The historical data trend for Actinogen Medical's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical YoY Rev. per Sh. Growth Chart

Actinogen Medical Annual Data

Trend

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

Actinogen Medical Semi-Annual Data
	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															-	-	-	-	-

Actinogen Medical YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Actinogen Medical's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY Rev. per Sh. Growth (A: Jun. 2024 )
=	(Revenue per Share (A: Jun. 2024 )	-	Revenue per Share (A: Jun. 2023 ))	/	\| Revenue per Share (A: Jun. 2023 ) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

Actinogen Medical's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=	(Revenue per Share (Q: Dec. 2023 )	-	Revenue per Share (Q: Dec. 2022 ))	/	\| Revenue per Share (Q: Dec. 2022 )) \|
=	(0	-	0)	/	\| 0 \|
=	N/A %

Actinogen Medical YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (OTCPK:ATGGF) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

3AC:Germany ACW:Australia

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.